Drugs / Bacille Calmette-Guerin
Bacille Calmette-Guerin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05820594 | Jun 2023 → Mar 2024 | tuberculosis | Liverpool School of Tropical Medicine | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bacille Calmette-Guerin | “Bacille Calmette-Guerin (BCG) is the only licensed vaccine against TB but has sub-optimal efficacy against pulmonary TB” PMID 39219857 ↗ Jun 2024 |
| Known as | bacillus calmette-guerin | “BCG (bacillus calmette-guerin) vaccine AJV” NCT05820594 ↗ |
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05820594 ↗ |
| Known as | BCG SSI | “BCG SSI vaccine into the upper arm on day 0 at three times the usual dose” NCT05820594 ↗ |
| Modality | Vaccine | “The only vaccine to prevent TB is called BCG (Bacillus Calmette-Guérin).” NCT05820594 ↗ |